Comparative assessment of efficacy and toxicity of R-DA-EPOCH and R-mNHL-BFM-90 induction courses in the treatment of patients with diffuse large B-cell lymphoma with poor prognostic factors in a randomized multicenter clinical trial “DLBCL-2015”

Background. Diffuse large B-cell lymphoma (DLBCL) is one of the most common and aggressive tumors of the lymphatic system. Despite the frequency of occurrence, there is no single algorithm for treating DLBCL patients with poor prognostic factors. R-CHOP therapy does not allow achieving long-term com...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: M. O. Bagova, A. U. Magomedova, S. K. Kravchenko, Ya. K. Mangasarova, O. V. Margolin, E. S. Nesterova, L. G. Gorenkova, A. E. Misyurina, E. A. Fastova, F. E. Babaeva, K. A. Sychevskaya, S. M. Kulikov, Yu. A. Chabaeva, V. G. Savchenko
Формат: Artigo
Язык:Russo
Опубликовано: ABV-press 2021-09-01
Серии:Onkogematologiâ
Предметы:
diffuse large b-cell lymphoma
toxicity
effectiveness
r-da-epoch
r-mnhl-bfm-90
Online-ссылка:https://oncohematology.abvpress.ru/ongm/article/view/491
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы